Clinical Trial Update: "Cancersensor" Metastasis Resection

View source ↗

Summary

A completed clinical trial evaluating the Cancersensor device for metastasis resection in metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Metastatic Colorectal Cancer | Status: COMPLETED